Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of competence in ultrasound-guided procedures-a generic assessment tool developed through the Delphi method

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prolonging fixation time of an alternative fixative to formalin for dermatological samples using standard laboratory protocols

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt-Jakob Disease Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The molecular profile of mucosal melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Treatment Algorithm for Advanced ALK-Rearranged NSCLC

    Research output: Contribution to journalLetterpeer-review

View graph of relations
Original languageEnglish
JournalClinical Lung Cancer
ISSN1525-7304
DOIs
Publication statusE-pub ahead of print - 2021

    Research areas

  • Alectinib hepatotoxicity, ALK, CNS efficacy of brigatinib, CNS relapse, Dose-escalated brigatinib

ID: 61923785